In particular, ER-positive, PR-positive, and HER2-negative human breast tumor samples showed the highest expression of HIF-1α. We also recorded that stage II and stage III tumors showed the highest expression of HIF-1α, indicating hypoxia enhances miRNA-induced aggressive breast cancer phenotypes at progressive disease states. Here, ERBB2 is linked to breast carcinoma.